Global Clinical Lead

Telix Pharmaceuticals (AMER)

4d•Hybrid

About The Position

The Global Clinical Lead is a significant subject matter expert (SME) role that exists within Telix to design, lead and implement the clinical development strategy for the Company’s Therapeutic assets. The Global Clinical Lead will lead the design of therapeutic clinical trials, including but not limited to protocol design, endpoints, eligibility criteria, and statistical plans. Thereby, the Global Clinical Lead, will ensure the therapeutic programs are founded on sound scientific decision-making and are able to be progressed efficiently and effectively towards commercial realization by generating high quality clinical data to serve the requirements of both internal stakeholders and external stakeholders including, but not limited to regulatory authorities, guidelines committees, payors, patient advocacy groups, and relevant business partners. In this role, the Global Clinical Lead will work closely in a matrix organization with the respective Global Program Heads, Clinical Operations, Regulatory Affairs, Medical Affairs, Therapeutic Business Unit Head and other relevant cross-functional teams to advance Telix Group’s therapeutic assets towards the clinic. This will be undertaken via a deep working knowledge of the existing and future competitive landscape in relevant cancer therapy areas.

Requirements

Medical degree (MD/MBBS) is required
Demonstrated experience in Oncology or Nuclear Medicine is required, with a strong understanding of the clinical and scientific landscape
5+ years of industry experience in clinical development, with a proven track record of leading clinical programs through early-phase development.
Solid understanding of global clinical trial methodology, regulatory frameworks, and submission processes.
Demonstrated success in leading cross-functional teams and managing complex clinical development programs from concept through execution
Strong knowledge of clinical trial design, data interpretation, and the ability to translate scientific insights into strategic development plans.

Nice To Haves

Experience in early-stage clinical trial design and execution is strongly preferred
Experience preparing and submitting regulatory documents (e.g., INDs, CTAs) and engaging with health authorities (e.g., FDA, EMA) is preferred

Responsibilities

Design, lead and implement Clinical Strategy: Define and drive the clinical development plans for Telix’s Therapeutic assets, ensuring alignment with Telix’s broader asset strategy and commercial objectives
Cross-functional collaboration: Partner closely with Global Program Heads, Clinical Operations, Regulatory Affairs, Medical Affairs, and the Therapeutic Business Unit Head to ensure clinical trial objectives are integrated into the overall development strategy and reflect the needs of internal and relevant external stakeholders
Clinical study design and execution: Oversee the development of clinical study plans from concept through to protocol finalization, ensuring scientific rigor and alignment with regulatory expectations, healthcare provider needs, patient advocacy perspectives, and market access requirements
Clinical documentation leadership: Lead the creation and review of essential clinical documentation - including informed consent forms, imaging charters, study manuals, and regulatory dossiers - in collaboration with medical writers and cross-functional teams
Regulatory and scientific contributions: Provide expert clinical input into key regulatory and scientific documents, including Investigator Brochures, IMPDs, DSURs, PSURs, SUSARs, Clinical Study Reports, and global regulatory submissions (e.g., INDs, BLAs, NDAs, MAAs)
Data integrity and analysis: Lead the review, interpretation, and quality control of clinical data, including efficacy, safety, and imaging endpoints, to ensure data integrity and support decision-making across the development lifecycle
Stakeholder communication: Prepare and deliver high-impact presentations, proposals, and reports for senior leadership, external partners, and strategic collaborators to communicate program progress and clinical insights
External engagement and thought leadership: Cultivate relationships with Key Opinion Leaders (KOLs), organize advisory boards, and collaborate with subject matter experts, consultants, and vendors to inform clinical strategy and enhance program visibility.